• Increase font size
  • Default font size
  • Decrease font size
home | about us | contact us
Search
Search Only:

Search Keyword accp

Total: 50 results found.

... potentially beneficial to the Deepwater Horizon Response effort. ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board:ACCP), a biopharmaceutical company specializing in products for cancer and supportive ...
DALLAS and NEW YORK, Aug. 24 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board:ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, announced ...
... Laboratories Inc. (A5 Labs) (OTCBB:AFLB) is pleased to provide an update on the company's business development activities for the month of July. Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP), ...
Phase I/II Clinical Trial to be conducted at UT MD Anderson Cancer CenterDALLAS and NEW YORK, Aug. 3 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP), today announced it ...
...  On heavy volume, shares CytRx rose nearly 8% or 7 cents to close the day at $0.95. ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board:ACCP.ob), a biopharmaceutical company specializing in products ...
DALLAS and NEW YORK, July 29 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, today ...
Zacks Investment Research has issued a research update summarizing some of the recent positive developments that Access Pharmaceuticals Inc. (OTC:ACCP.OB) has been able to achieve which have led to reiteration ...
... methylation markers are required to detect most cancers and pre-cancers. Exact Sciences gained 23 cents or 6.22% on the news. ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board:ACCP.ob), a biopharmaceutical ...
DALLAS and NEW YORK, July 27 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, today ...
... Board:ACCP.ob), announced today it has signed an exclusive specialty distribution agreement with BioScrip (Nasdaq:BIOS) for its lead product, MuGard -- an FDA-approved, ready-to-use mucoadhesive oral wound ...
... Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has signed an exclusive specialty distribution agreement with BioScrip (Nasdaq: BIOS) ...
... moved up 2%. Shares of NBYT closed up $16.27 or 43.42 % to $53.74. Access Pharmaceuticals, Inc. (OTC Bulletin Board:ACCP.ob), announced today that it has entered into a pre-licensing feasibility agreement ...
DALLAS and NEW YORK, July 15 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP), announced today that it has entered into a pre-licensing feasibility agreement with a leading ...
... INC. (OTC Bulletin Board:ACCP.ob) President and CEO Jeffrey B. Davis will present at the One Med Forum: Emerging Company Finance Conference on Wednesday, June 30th at 9:20 AM ET. The conference is being ...
As a follow up to our subscriber alert and article about Access Pharmaceuticals' (ACCP.OB) presentation at the Multinational Association of Supportive Care in Cancer (MASCC) Conference in Vancouver, ...
As we told our subscribers yesterday, Access Pharmaceuticals (ACCP.OB) is presenting a scientific poster today at the Multinational Association of Supportive Care in Cancer (MASCC) Conference ...
DALLAS and NEW YORK -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, is presenting a scientific poster ...
18. Alert: Key Data Could Drive Stock Price
(Premium Content/Subscriber Only Content)
... in Vancouver, B.C. According to some of the chatter we are hearing, that data is going to be presented by Access Pharmaceuticals (OTC: ACCP) and when it is released, it could affect the price of the ...
... executive officer of VIVUS. Also Tuesday: Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, is sponsoring ...
... (IGPA) and American College of Clinical Pharmacology (ACCP). Prior to joining CEDRA, Pottier held positions with Novum Pharmaceutical Research Services and PRACS Institute, Ltd./Cetero Research, which ...
DALLAS and NEW YORK-- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, is sponsoring an Oral Mucositis Symposium ...
... (AAPS), Drug Information Association (DIA), Generic Pharmaceutical Association (GPhA), International Generic Pharmaceutical Alliance (IGPA) and American College of Clinical Pharmacology (ACCP). Prior ...
...  DALLAS and NEW YORK, June 15 /PRNewswire-FirstCall/ --  ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing ...
... INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, announced that its Senior VP of R&D, David Nowotnik, Ph.D., will give two presentations ...
DALLAS -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, announced that its Senior VP of R&D, David ...
... for the American College of Chest Physicians (ACCP). Dr. Jonathan Corren - Associate Clinical Professor of Medicine at the University of California, Los Angeles, where he is active in the training ...
DALLAS and NEW YORK, May 19 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, announced ...
... negotiating commercial agreements over the coming months. To support these efforts CAL-SAN is in the final stages of implementing a HACCP quality control production system, acquiring new packaging equipment ...
... which not only meet HACCP, ISO9001, GMP and Organic quality requirements, but also comply with FDA and European pharmaceutical standards. For further information or comment please contact: Dr Helen Fitton ...
... Marketing and Chief Marketing Officer at BMS Company.. In news from earlier in the day: ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board:ACCP.ob), a biopharmaceutical company specializing in products ...
DALLAS and NEW YORK, April 21 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, announced ...
DALLAS and NEW YORK, April 19 /PRNewswire-FirstCall/ -- Jeffrey Davis, President and CEO of ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products ...
... the United States, is not presently marketed anywhere in the world. In news from earlier in the day: ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board:ACCP.ob), jumped higher after the biopharmaceutical ...
DALLAS and NEW YORK, April 15 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, announced ...
DALLAS and NEW YORK, April 13 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced that it has completed its first commercial scale production run of MuGard in North ...
... Tefferi, Professor of Hematology at Mayo Graduate School and Chair of the study. Also Tuesday: Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP) signed a collaborative development agreement with ...
DALLAS -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) signed a collaborative development agreement with bioRASI, LLC, a full-service global CRO specializing in the accelerated development ...
... public review at www.sedar.com. Summary of Q4 Events Receipt of ISO 22000, HACCP and GMP Certification Completion of US FDA GRAS Self-affirmation Filing of Toasted Meal patent application Receipt ...
... center of research on the effects of drugs and alcohol on driving performance. Also Thursday: ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced that JCOM Co., Ltd., its Korean licensee ...
DALLAS -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced that JCOM Co., Ltd., its Korean licensee for both MuGard™ and ProLindac™,  has received approval from the Korean Food and Drug ...
...  Also Thursday: ACCESS PHARACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced that it has received reports of significant bioavailability of orally delivered insulin in two independently-conducted ...
DALLAS -- ACCESS PHARACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced that it has received reports of significant bioavailability of orally delivered insulin in two independently-conducted animal ...
Access Pharmaceuticals, Inc. (OTCBB: ACCP) announced that it has received reports of significant bioavailability of orally delivered insulin in two independently-conducted animal studies. The studies, ...
... due to the unique culturing method Supported by more than 70 scientific reports, including 35 human clinical trials Manufactured in a HACCP certified facility BB536 added product has been approved ...
... conducts fish processing, production and sales with operations based in the island province of Hainan, in the South China Sea. The Company holds HACCP and GMP certification from the U.S. FDA and the EU ...
Access Pharma (OTC: ACCP.OB) is an emerging bio-pharmaceutical company which is focusing on the development of a late-stage, diversified oncology pipeline in addition to a treatment called MuGard that ...
Technology Is Seen As Providing Missing Link In Commercial Development Of Promising siRNA TherapiesDALLAS, Feb. 4 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced ...
DALLAS, Feb. 2 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today announced that it closed its previously announced sale of approximately 2.10 million shares oits ...
... on Friday: Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP), today announced that it has entered into definitive agreements with accredited investors to sell in a registered direct offering an ...
DALLAS -- Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP), today announced that it has entered into definitive agreements with accredited investors to sell in a registered direct offering an ...

Get Free Email and Phone News Alerts

* Your email address:
* Preferred Format:
* Enter the security code shown:
 
Home | Privacy Policy
© 2010 BioMedReports.com. All rights reserved